[1] |
邱轩, 徐晓蒙, 刘宽芝. 关于肥胖, 你知道多少?[J]. 临床荟萃, 2017, 32(9): 812.
|
[2] |
Aminian A, Chang J, Brethauer SA, et al. Asmbs updated position statement on bariatric surgery in class I obesity (BMI 30-35 kg/m2)[J]. Surg Obes Relat Dis, 2018, 14(8): 1071-1087.
doi: S1550-7289(18)30293-4
pmid: 30061070
|
[3] |
Gasoyan H, Tajeu G, Halpern MT, et al. Reasons for underutilization of bariatric surgery: The role of insurance benefit design[J]. Surg Obes Relat Dis, 2019, 15(1): 146-151.
doi: S1550-7289(18)30505-7
pmid: 30425002
|
[4] |
中华医学会消化内镜学分会微创减重治疗协作组, 中国医师协会消化医师分会减重专业委员会, 国家消化系统疾病临床医学研究中心(北京). 中国肥胖症消化内镜治疗专家共识[J]. 中华消化内镜杂志, 2024, 41(1): 1-10.
|
[5] |
Kim BY, Kang SM, Kang JH, et al. 2020 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea[J]. J Obes Metab Syndr, 2021, 30(2): 81-92.
|
[6] |
Seo MH, Lee WY, Kim SS, et al. 2018 Korean society for the study of obesity guideline for the management of obesity in Korea[J]. J Obes Metab Syndr, 2019, 28(1): 40-45.
|
[7] |
Wei Y, Li P, Zhang S. From surgery to endoscopy: The evolution of the bariatric discipline[J]. Chin Med J (Engl), 2022, 135(20): 2427-2435.
|
[8] |
Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for metabolic and bariatric surgery[J]. Surg Obes Relat Dis, 2022, 18(12): 1345-1356.
doi: 10.1016/j.soard.2022.08.013
pmid: 36280539
|
[9] |
Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity[J]. Lancet, 1982, 1(8265): 198-199.
pmid: 6119560
|
[10] |
王战建. 肥胖症的诊断治疗进展[J]. 临床荟萃, 2002, 17(2): 123-125.
|
[11] |
Dantas ACB. Comment on: “IFSO survey: Metabolic and bariatric surgery indications and coverage worldwide”[J]. Obes Surg, 2024, 34(5): 1405-1406.
|
[12] |
Courcoulas AP. New indications for metabolic and bariatric surgery[J]. Lancet Diabetes Endocrinol, 2023, 11(3): 151-153.
|
[13] |
De peppo F, Caccamo R, Adorisio O, et al. The Obalon swallowable intragastric balloon in pediatric and adolescent morbid obesity[J]. Endosc Int Open, 2017, 5(1): E59-E63.
|
[14] |
Dolan RD, Schulman AR. Endoscopic approaches to obesity management[J]. Annu Rev Med, 2022, 73: 423-438.
|
[15] |
Muniraj T, Day LW, Teigen LM, et al. AGA clinical practice guidelines on intragastric balloons in the management of obesity[J]. Gastroenterology, 2021, 160(5): 1799-1808.
doi: 10.1053/j.gastro.2021.03.003
pmid: 33832655
|
[16] |
Velchik MG, Kramer FM, Stunkard AJ, et al. Effect of the Garren-Edwards gastric bubble on gastric emptying[J]. J Nucl Med, 1989, 30(5): 692-696.
pmid: 2715831
|
[17] |
刘南, 郭瑾陶, 孙思予. 内镜技术在减重治疗中的应用进展[J]. 中国实用内科杂志, 2023, 43(1): 78-83.
|
[18] |
Jaleel R, Kapoor N, Kalra S. Endoscopic intragastric balloon: A novel therapy for weight loss[J]. J Pak Med Assoc, 2022, 72(7): 1444-1446.
doi: 10.47391/JPMA.22-78
pmid: 36156579
|
[19] |
Pessorrusso F, Mehta SV, Sullivan S. Update on endoscopic treatments for obesity[J]. Curr Obes Rep, 2024, 13(2): 364-376.
doi: 10.1007/s13679-024-00551-6
pmid: 38388770
|
[20] |
Rzepa A, Karpinska I, Wierdak M, et al. Effect of preoperative intragastric balloon treatment on perioperative and postoperative outcomes after laparoscopic sleeve gastrectomy: A retrospective cohort study[J]. Pol Przegl Chir, 2024, 96(3): 56-62.
doi: 10.5604/01.3001.0054.2675
pmid: 38940249
|
[21] |
Swei E, Almuhaidb A, Sullivan S, et al. Comparison of the efficacy and safety of the FDA-approved intragastric balloon systems in a clinical setting[J]. J Clin Gastroenterol, 2023, 57(6): 578-585.
|
[22] |
Tate CM, Geliebter A. Intragastric balloon treatment for obesity: Review of recent studies[J]. Adv Ther, 2017, 34(8): 1859-1875.
doi: 10.1007/s12325-017-0562-3
pmid: 28707286
|
[23] |
Turkeltaub JA, Edmundowicz SA. Endoscopic bariatric therapies: Intragastric balloons, tissue apposition, and aspiration therapy[J]. Curr Treat Options Gastroenterol, 2019, 17(2): 187-201.
doi: 10.1007/s11938-019-00232-7
pmid: 30963378
|
[24] |
Fittipaldi-fernandez RJ, Zotarelli-filho IJ, Diestel CF, et al. Randomized prospective clinical study of spatz3(R) adjustable intragastric balloon treatment with a control group: A large-scale Brazilian experiment[J]. Obes Surg, 2021, 31(2): 787-796.
|
[25] |
Das SS, Bondok W, Jafri IF, et al. Acute necrotizing pancreatitis following intragastric balloon insertion[J]. Cureus, 2024, 16(2):e54437.
|
[26] |
王勇, 谢佳冀. 减重及代谢外科手术的关键技术标准及评价[J]. 中国实用外科杂志, 2024, 44(1): 70-73.
|
[27] |
Abu Dayyeh BK, Rajan E, Gostout CJ. Endoscopic sleeve gastroplasty: A potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity[J]. Gastrointest Endosc, 2013, 78(3): 530-535.
doi: 10.1016/j.gie.2013.04.197
pmid: 23711556
|
[28] |
Nduma BN, Mofor KA, Tatang J, et al. Endoscopic sleeve gastroplasty (ESG) versus laparoscopic sleeve gastroplasty (LSG): A comparative review[J]. Cureus, 2023, 15(7): e41466.
|
[29] |
Lopez-nava G, Sharaiha RZ, Vargas EJ, et al. Endoscopic sleeve gastroplasty for obesity: A multicenter study of 248 patients with 24 months follow-up[J]. Obes Surg, 2017, 27(10): 2649-2455.
doi: 10.1007/s11695-017-2693-7
pmid: 28451929
|
[30] |
Abu dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): A prospective, multicentre, randomised trial[J]. Lancet, 2022, 400(10350): 441-451.
doi: 10.1016/S0140-6736(22)01280-6
pmid: 35908555
|
[31] |
Brunaldi VO, Neto MG. Endoscopic procedures for weight loss[J]. Curr Obes Rep, 2021, 10(3): 290-300.
doi: 10.1007/s13679-021-00450-0
pmid: 34297346
|
[32] |
Alqahtani A, Elahmedi M, Alqahtani YA, et al. Endoscopic sleeve gastroplasty in 109 consecutive children and adolescents with obesity: Two-year outcomes of a new modality[J]. Am J Gastroenterol, 2019, 114(12): 1857-1862.
doi: 10.14309/ajg.0000000000000440
pmid: 31658128
|
[33] |
Nystrom M, Machytka E, Noren E, et al. Aspiration therapy as a tool to treat obesity: 1- to 4-year results in a 201-patient multi-center post-market european registry study[J]. Obes Surg, 2018, 28(7): 1860-1868.
doi: 10.1007/s11695-017-3096-5
pmid: 29388050
|
[34] |
Hadefi A, Arvanitakis M, Huberty V, et al. Metabolic endoscopy: Today's science-tomorrow's treatment[J]. United European Gastroenterol J, 2020, 8(6): 685-694.
|
[35] |
Reja D, Zhang C, Sarkar A. Endoscopic bariatrics: Current therapies and future directions[J]. Transl Gastroenterol Hepatol, 2022, 7: 21.
doi: 10.21037/tgh.2020.03.09
pmid: 35548475
|
[36] |
Ren M, Zhou X, Yu M, et al. Prospective study of a new endoscopic duodenal-jejunal bypass sleeve in obese patients with nonalcoholic fatty liver disease (with video)[J]. Dig Endosc, 2023, 35(1): 58-66.
|
[37] |
Mingrone G, Van baar AC, Deviere J, et al. Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: The randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial[J]. Gut, 2022, 71(2): 254-264.
|
[38] |
Courcoulas AP, Daigle CR, Arterburn DE. Long term outcomes of metabolic/bariatric surgery in adults[J]. BMJ, 2023, 383: e071027.
|